HMG-CoA reductase inhibitors, gemfibrozil, and myopathy
- 15 April 1995
- journal article
- other
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (12) , 862
- https://doi.org/10.1016/s0002-9149(99)80435-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Safety of combined pravastatin-gemfibrozil therapyThe American Journal of Cardiology, 1994
- The replyThe American Journal of Medicine, 1994
- A multicenter comparative trial of lovastatin and pravastatin in the treatment of hypercholesterolemiaThe American Journal of Cardiology, 1993
- Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemiaThe American Journal of Medicine, 1993
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987